openPR Logo
Press release

Research foresees the L-Hydroxyphenylalanine Market to expand at a meteoric CAGR of 3.5% by 2018 to 2028

10-09-2018 05:33 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Research foresees the L-Hydroxyphenylalanine Market to expand

As a part of the amino acid family, use of L-hydroxyphenylalanine as an energy providing aromatic ingredient has significantly fuelled its demand across the dietary supplement and nutraceuticals space. This factor continues to remain instrumental in driving the growth of the L-hydroxyphenylalanine market during the period of forecast. Moreover, various pharmaceutical uses of L-hydroxyphenylalanine including its application in formulations to treat Parkinson’s disease, Alzheimer’s disease and cancer are also expected to contribute to the overall growth of the L-hydroxyphenylalanine market. Being recognized as GRAS (Generally Recognized as Safe) by the FDA, the use of L-hydroxyphenylalanine in food and beverage sector has also witnessed significant growth in recent times.

A new research study by Fact.MR reveals growth pathways for L-hydroxyphenylalanine from a global viewpoint during the period of forecast, 2018-2028. The report includes estimations that reflect global sales of L-hydroxyphenylalanine which are expected to cross US$ 1,500 Mn by end of the year of assessment (2028). The sales of L-hydroxyphenylalanine are expected to remain concentrated in the developed countries of North America and emerging economies in the Asia Pacific excluding Japan (APEJ) region, given the increasing demand for L-hydroxyphenylalanine in anti-ageing creams and as effective adjuvant in cancer treatment in these regions.

You can Get Free Sample Report Here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=918

L-Hydroxyphenylalanine Market: Use of L-Hydroxyphenylalanine in Dietary Supplements to Spearhead in the Coming Years

Dietary supplements and nutraceuticals have witnessed significant proliferation across various countries worldwide, given the increasing consumer awareness regarding healthy diet and exercise. Moreover, the growing number of individuals participating in heavy physical activities has further complemented the use of supplements for enhancing muscle growth. Being an amino acid, L-hydroxyphenylalanine as an energy ingredient has witnessed high demand in the production of health supplements, which is expected to fuel the growth of the L-hydroxyphenylalanine market during the period of forecast.

L-Hydroxyphenylalanine Market: High Prevalence of Parkinson’s Disease to Call for Efficient Treatment Solutions

Parkinson’s disease is directly associated with low blood pressure and orthostatic hypotension, that translates into need for effective pharmaceutical formulations that facilitate high energy flow and increase the heart rate. That said, L-hydroxyphenylalanine plays an imperative role in producing significant amount of energy that improves parkinsonian orthostatic hypotension and raises blood pressure, causing the shaking of body to reduce drastically. This factor coupled with increasing cases of Parkinson’s disease across the globe has enhanced the demand of L-hydroxyphenylalanine, in turn contributing to the growth of the L-hydroxyphenylalanine market during the period of forecast.

Report Analysis@ https://www.factmr.com/report/918/l-hydroxyphenylalanine-market

L-Hydroxyphenylalanine Market: Melanoma Treatment to Create Potential Avenues

Treatment of melanoma is expected to pave significant pathways for growth of the L-hydroxyphenylalanine market, as studies reveal the potential of the L-hydroxyphenylalanine in production of melanin. The Federation of American Societies for Experimental Biology Journal has highlighted the link between mitochondrial function and production of melanin in cancerous skin cells. Post examination revealed that the rate of Reactive Oxygen Species generation in darker cells were high as compared to medium and low level pigments. Provision of L-hydroxyphenylalanine as a building block for melanin production, has been used to activate medium and light cells to increase the production of melanin. This concept is expected to trigger coupling cellular adaptation and stress signaling through ROS signaling, which in turn has the potential to support development of anti-cancer drugs for treating melanoma. This approach is expected provide substantial growth opportunities for the use L-hydroxyphenylalanine, consequently fuelling the growth of the L-hydroxyphenylalanine market during the forecast period.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research foresees the L-Hydroxyphenylalanine Market to expand at a meteoric CAGR of 3.5% by 2018 to 2028 here

News-ID: 1291495 • Views:

More Releases from Fact.MR

Driver Monitoring Camera and Sensor Systems Industry Projected to Grow at 11.1% CAGR, Driven by Continental AG, Bosch, Valeo
Driver Monitoring Camera and Sensor Systems Industry Projected to Grow at 11.1% …
The global driver monitoring camera and sensor systems market is entering a high-growth phase as automakers, regulators, and mobility technology providers increasingly prioritize in-cabin safety, driver behavior analysis, and advanced driver assistance systems (ADAS). According to Fact.MR, the market was valued at USD 2.74 billion in 2025 and is projected to grow from USD 3.06 billion in 2026 to USD 8.78 billion by 2036, expanding at a CAGR of 11.1%
Herbal Supplements Move Into the Mainstream as Global Market Eyes $116.6 Billion by 2036
05-13-2026 | Health & Medicine
Fact.MR
Herbal Supplements Move Into the Mainstream as Global Market Eyes $116.6 Billion …
Rockville, MD / According to Fact.MR analysis, the global herbal supplement industry is entering a new phase of commercial maturity, shifting from a niche wellness category into a mainstream consumer health segment with growing relevance for retailers, healthcare stakeholders, investors, and consumer packaged goods companies. Rising preventive healthcare awareness, increasing acceptance of plant-based formulations, and the rapid expansion of digital wellness ecosystems are reshaping demand patterns across developed and emerging
Vinasse Market Transforms from Industrial By-product to Circular Economy Asset as Global Market Approaches $3.3 Billion by 2036
05-13-2026 | Health & Medicine
Fact.MR
Vinasse Market Transforms from Industrial By-product to Circular Economy Asset a …
Rockville, MD / According to Fact.MR analysis, the global vinasse industry is evolving from a traditional waste management challenge into a commercially valuable circular economy segment with increasing relevance for agriculture companies, bioenergy producers, sugar and ethanol processors, environmental management firms, and industrial sustainability stakeholders. Growing demand for organic fertilizers, rising bioenergy investment, and tightening environmental regulations surrounding industrial waste disposal are reshaping how vinasse is processed, commercialized, and integrated
Seat Comfort and Lumbar Actuator Systems Gain Strategic Importance as Smart Cabin Comfort Market Eyes $16.9 Billion by 2036
05-13-2026 | Health & Medicine
Fact.MR
Seat Comfort and Lumbar Actuator Systems Gain Strategic Importance as Smart Cabi …
Rockville, MD / According to Fact.MR analysis, the global seat comfort and lumbar actuator systems industry is entering a new phase of automotive interior transformation, evolving from a premium convenience feature into a core component of modern cabin experience design. Automakers are increasingly integrating powered seat adjustment, lumbar support, massage functionality, and memory-linked comfort systems across broader vehicle segments as consumers place higher value on ergonomic comfort, personalized interiors, and

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082 The report provides a comprehensive analysis of company profiles listed below: - Teva - Roche - Prothena - Acorda
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Parkinson’s Disease Treatment with respect
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial